id: NEW:ultra_processed_food_consumption_to_NEW:non_alcoholic_fatty_liver_disease
name: Ultra-Processed Food Consumption â†’ Non-Alcoholic Fatty Liver Disease (NAFLD)
from_node:
  node_id: NEW:ultra_processed_food_consumption
  node_name: Ultra-Processed Food Consumption
to_node:
  node_id: NEW:non_alcoholic_fatty_liver_disease
  node_name: Non-Alcoholic Fatty Liver Disease (NAFLD)
direction: positive
category: behavioral
mechanism_pathway:
- 'Step 1: Ultra-processed foods are consumed regularly, characterized by high energy
  density, added sugars, unhealthy fats, and low fiber content as classified by the
  NOVA food classification system'
- 'Step 2: Chronic caloric excess from UPF consumption promotes positive energy balance,
  leading to weight gain and development of overweight/obesity'
- 'Step 3: Excess caloric intake and associated metabolic dysfunction promote hepatic
  de novo lipogenesis and increased free fatty acid flux to the liver'
- 'Step 4: Accumulation of triglycerides in hepatocytes leads to hepatic steatosis,
  the hallmark of NAFLD'
- 'Step 5: UPF consumption also contributes to metabolic syndrome and type 2 diabetes,
  which are strongly associated with NAFLD progression'
evidence:
  quality_rating: A
  n_studies: 9
  primary_citation: 'Alex E. Henney et al. 2023. Ultra-Processed Food Intake Is Associated
    with Non-Alcoholic Fatty Liver Disease in Adults: A Systematic Review and Meta-Analysis.
    Nutrients.'
  supporting_citations: []
description: A systematic review and meta-analysis of 9 studies (3 cross-sectional,
  3 case-control, 3 cohort) analyzing 60,961 individuals found that ultra-processed
  food consumption is significantly associated with increased risk of non-alcoholic
  fatty liver disease. The relationship shows a dose-response effect, with high UPF
  intake associated with 42% increased risk of NAFLD compared to low intake. The mechanism
  operates through chronic caloric excess, promotion of obesity, metabolic syndrome,
  and type 2 diabetes, all of which contribute to hepatic fat accumulation.
last_updated: '2025-12-02'
extraction_method: consolidated_batch_v3
quantitative_effects:
  effect_size:
    value: 1.42
    type: relative_risk
    ci_lower: 1.16
    ci_upper: 1.75
  p_value: 0.01
  sample_size: 60961
moderators:
- name: dose_level
  direction: strengthens
  strength: strong
  description: 'Dose-response relationship observed: moderate UPF intake (vs. low)
    showed RR 1.03 (1.00-1.07), while high UPF intake (vs. low) showed RR 1.42 (1.16-1.75),
    demonstrating significantly stronger effects with higher consumption'
